Ambea AB (publ) AMBEA
Email when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
The news check keeps the assessment current.
General analysis — not personal advice.
Existing positions can be maintained while new purchases await clearer signals on Humana integration.
Strong growth and profitability are balanced by high leverage and integration risks around Humana, supporting the hold signal.
The market reacts positively to the strong Q3 report and the Humana bid, with analysts reiterating buy recommendations.
HOLD is the call. Positive is the market mood. Medium risk means some things can go wrong.
Latest change
- 5 Nov 2026 — The report beat expectations driven by strong organic growth and margin improvements.
The full analysis is open. Follow the company free for the full change history — and email next time the picture changes.
Show all changes (2) — follow the company freeAbout the company
Ambea is one of the leading private care providers in the Nordics with operations in Sweden, Norway, Denmark and Finland. The company operates residential care and support services within elderly care, disability care and individual and family care under brands such as Vardaga, Nytida and Stendi.
Bull case
Strong organic growth, improved margins and the Humana deal drive profitability higher.
Bear case
High leverage and integration risks around Humana may limit flexibility.
Sensitivity analysis
| Factor | If it weakens | If it strengthens |
|---|---|---|
| Humana integration | Delayed or costly integration → synergies fail to materialise and debt remains elevated. | Fast and cost-efficient integration → margin improvement accelerates and Nordic position strengthens. |
| Occupancy rate | Lower occupancy → revenue and margin growth slows. | Higher occupancy → profitability improves faster than expected. |
Why this signal
Strong growth and profitability are balanced by high leverage and integration risks around Humana, supporting the hold signal.
Recent news
Ambea published the Q3 report on 4 November with net sales of SEK 4,447 m and adjusted EBITA of SEK 668 m that beat expectations. The company has completed the Humana acquisition with 98 % ownership and initiated squeeze-out.